Today in London the FDA decided to postpone approval of a new experimental heart drug, seeking more information about the new product. The drug called Certriad, combines AstraZeneca’s blockbuster cholesterol pill Crestor with Abbott Laboratories TriLipix. According to Rueters, The manufacturers said on Tuesday they had received a so-called “complete response letter” from the U.S. [...]
According to reports, the axe is coming down all over the pharma world on research and development projects that are not yielding immediate results. AstraZeneca(Atacand, Crestor), GlaxoSmithKline (Advair, Boniva) and Pfizer (Benadryl, Lipitor) have all already begun to scrap projects, while others like Sanofi-Aventis (Allegra, Plavix) are about to pick up the trend and start [...]
Painful conditions of the esophagus and stomach are common in our society. Stress, obesity, poor diet, and smoking can all play a part. Whether you suffer from acid reflux or ulcers, controlling acid is probably part of your game plan for comfort and health. But there are two very similar acid-controlling drugs from the same [...]
A diagnosis of high cholesterol can be intimidating, but there is a lot you can do to control this condition. In addition to modifying your diet and upping your exercise, the addition of a HMG-CoA Reductase Inhibitor — a class of drugs commonly called “statins” — can safely and effectively lower your cholesterol. (HMG-CoA Reductase [...]
Well, disgraced AstraZeneca sales exec Mike Zubillaga has finally removed his foot from his mouth and broken his silence. Via Pharmalot, here’s what Mike had to say: It’s been an absolutely horrible week. I don’t wish this on anyone. But I have to move on. I have a family to take care of…I hold no [...]
Today would not be a good time to be Michael Zubillaga. The regional sales director for AstraZeneca was fired Friday after he made the following statement in an internal oncology newsletter: I see it like this: there is a big bucket of money sitting in every (cancer doctor’s) office. Every time you go in, you [...]
A series of recent high-profile drug failures has AstraZeneca’s chief executive David Brennan in search of new drugs for his pipeline. The London Times states, As well as being costly, the failures have left the group dangerously exposed, with just a few products left in its late-stage pipeline and with patents on its existing line [...]
